Lower extremity amputation risk was lower among users of SGLT-2 inhibitors vs DPP-4 inhibitors but higher among users of SGLT-2 inhibitors vs sulfonylureas. Among patients with type 2 diabetes, sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results